试验雷达 AI | ||
|---|---|---|
临床试验 NCT03155594 针对糖尿病目前状态未知。请查看临床试验雷达卡片视图和 AI 发现工具了解所有详情，或在此提出任何问题。 | ||
一个试验符合筛选条件
卡片视图
CGM to Aid Transition From Inpatient to Outpatient 15
临床试验详情主要以英语提供。然而，试验雷达 AI可以提供帮助！只需点击“试验详解”即可查看和讨论您选择的语言的试验信息。
临床试验NCT03155594是一项针对糖尿病的干预性研究试验，目前试验状态为状态未知。试验始于2017年5月9日，计划招募15名患者。该研究由Methodist Medical Center of Illinois主导，预计于2017年8月1日完成。试验数据来源于ClinicalTrials.gov，最后更新时间为2017年5月16日。
简要概括
A pilot study using the FreeStyle Libre to assess its potential benefits in patients with diabetes starting when they are inpatients and continuing during the transition of care to the outpatient setting to see if diabetes care can be improved after discharge.
This study is designed to address the following questions:
- How do the glucose readings from FreeStyle Libre Pro compare to our inpatient glucometer system...
详细描述
Continuous glucose monitoring checks blood glucose continuously. This allows the patient and provider to see what the glucose does between finger stick measurements. The FreeStyle Libre, is a sensor patch that can continuously measure glucose for up to two weeks.
Objectives To see if new continuous glucose technology can 1) Improve glucose management in the hospital compared to finger sticks 4-5 times per day. 2) He...
显示更多官方标题
Continuous Glucose Monitoring in the Hospital to Aid in Care and Improve Transition of Care to Outpatient
疾病
糖尿病出版物
关于此临床试验发表的科学文章和研究论文：其他研究标识符
- 1023056-2
NCT编号
实际开始日期
2017-05-09
最近更新发布
2017-05-16
预计完成日期
2017-08-01
计划入组人数
15
研究类型
干预性研究
试验分期 (阶段)
不适用
试验状态
状态未知
关键词
Diabetes
Diabetes Mellitus
Diabetes Type 1
Diabetes Type 2
CGM
Continuous Glucose Monitoring
Inpatient
Outpatient
Transition of care
DM-1
DM-2
Freestyle Libre
Diabetes Mellitus
Diabetes Type 1
Diabetes Type 2
CGM
Continuous Glucose Monitoring
Inpatient
Outpatient
Transition of care
DM-1
DM-2
Freestyle Libre
主要目的
治疗方法
分配方式
不适用
干预模型
单组试验
盲法
无（开放性试验）
试验组/干预措施
| 参与者组/试验组 | 干预措施/治疗方法 |
|---|---|
实验性Single arm Patients in this trial will receive a FreeStyle Libre patch that continuously measures glucose in addition to their standard glucose monitoring. | Freestyle Libre Continuous glucose monitoring patch |
主要终点
次要终点
| 结果指标 | 度量标准描述 | 时间框架 |
|---|---|---|
Changes in care | Each day a clinician from the Diabetes Service sees a patient in the hospital or office setting after discharge, they will download the information in the sensor patch. The clinician will note on the data collection sheet if the additional information changed the care compared to the information available from the hospital and patient glucose testing. | 2 weeks |
| 结果指标 | 度量标准描述 | 时间框架 |
|---|---|---|
Accuracy of device | Each glucometer glucose and serum glucose will be compared to the readings from the sensor patch. | 2 weeks |
资格标准
适龄参与研究
成人, 老年人
最低年龄要求
18 Years
适龄性别
全部
- Inpatients on insulin therapy 18 years and older on insulin with glucose testing 4-5 times per day
- Patient able to sign informed consent.
- Patient unable to give informed consent
- Critically ill patients will not be started in the CGM patch, but he patch will not be removed if transferred to ICU.
- Patients currently on acetaminophen
- Currently on diathermy treatments
- Pregnancy
- Dialysis
- Currently on vitamin C
- Patient is sensitive to the adhesive or develops significant skin irritation.
- Treatment for dehydration
Methodist Medical Center of Illinois研究责任方
Anne Webster, APN, 主要研究者, APN, Methodist Medical Center of Illinois
没有联系数据。
1 位于 1 个国家/地区的研究中心
Illinois
Methodist Medica Center of Illinois, Peoria, Illinois, 61602, United States